292 related articles for article (PubMed ID: 21296386)
1. Vitamin E inhibition on platelet procoagulant activity: involvement of aminophospholipid translocase activity.
Kim JE; Han M; Hanl KS; Kim HK
Thromb Res; 2011 May; 127(5):435-42. PubMed ID: 21296386
[TBL] [Abstract][Full Text] [Related]
2. Persistence of procoagulant surface expression on activated human platelets: involvement of apoptosis and aminophospholipid translocase activity.
Leung R; Gwozdz AM; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
J Thromb Haemost; 2007 Mar; 5(3):560-70. PubMed ID: 17155950
[TBL] [Abstract][Full Text] [Related]
3. Merocyanine 540 as a fluorescent probe of altered membrane phospholipid asymmetry in activated whole blood platelets.
Watala C; Waczulikova I; Wieclawska B; Rozalski M; Gresner P; Gwoździński K; Mateasik A; Sikurova L
Cytometry; 2002 Nov; 49(3):119-33. PubMed ID: 12442312
[TBL] [Abstract][Full Text] [Related]
4. Calpain inhibition by calpeptin does not prevent APLT activity reduction in PS-exposing platelets, but calpeptin has independent pro-apoptotic effects.
Gwozdz AM; Leung R; Wang H; Bang KW; Packham MA; Freedman J; Rand ML
Thromb Haemost; 2010 Jun; 103(6):1218-27. PubMed ID: 20352156
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporine enhances platelet procoagulant activity.
Tomasiak M; Rusak T; Gacko M; Stelmach H
Nephrol Dial Transplant; 2007 Jun; 22(6):1750-6. PubMed ID: 17308321
[TBL] [Abstract][Full Text] [Related]
6. L-carnitine inhibits a subset of platelet activation responses in chronic uraemia.
Bonomini M; Sirolli V; Dottori S; Amoroso L; Di Liberato L; Arduini A
Nephrol Dial Transplant; 2007 Sep; 22(9):2623-9. PubMed ID: 17478491
[TBL] [Abstract][Full Text] [Related]
7. Arsenite-enhanced procoagulant activity through phosphatidylserine exposure in platelets.
Bae ON; Lim KM; Noh JY; Chung SM; Kim H; Lee CR; Park JD; Chung JH
Chem Res Toxicol; 2007 Dec; 20(12):1760-8. PubMed ID: 17915961
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of platelet aggregation and aminophospholipid exposure by calpain.
Bachelot-Loza C; Badol P; Brohard-Bohn B; Fraiz N; Cano E; Rendu F
Br J Haematol; 2006 May; 133(4):419-26. PubMed ID: 16643450
[TBL] [Abstract][Full Text] [Related]
9. Vasopressin acts on platelets to generate procoagulant activity.
Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):615-24. PubMed ID: 18832900
[TBL] [Abstract][Full Text] [Related]
10. The involvement of Na+/K(+)-ATPase in the development of platelet procoagulant response.
Tomasiak M; Stelmach H; Rusak T; Ciborowski M; Radziwon P
Acta Biochim Pol; 2007; 54(3):625-39. PubMed ID: 17653302
[TBL] [Abstract][Full Text] [Related]
11. Silver nanoparticles enhance thrombus formation through increased platelet aggregation and procoagulant activity.
Jun EA; Lim KM; Kim K; Bae ON; Noh JY; Chung KH; Chung JH
Nanotoxicology; 2011 Jun; 5(2):157-67. PubMed ID: 20822370
[TBL] [Abstract][Full Text] [Related]
12. Aminophospholipid translocase and phospholipid scramblase activities in sickle erythrocyte subpopulations.
Barber LA; Palascak MB; Joiner CH; Franco RS
Br J Haematol; 2009 Aug; 146(4):447-55. PubMed ID: 19549270
[TBL] [Abstract][Full Text] [Related]
13. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction.
Wolfs JL; Comfurius P; Rasmussen JT; Keuren JF; Lindhout T; Zwaal RF; Bevers EM
Cell Mol Life Sci; 2005 Jul; 62(13):1514-25. PubMed ID: 15971000
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-induced platelet procoagulant activities: an important clue for chemotherapy-associated thrombosis.
Kim SH; Lim KM; Noh JY; Kim K; Kang S; Chang YK; Shin S; Chung JH
Toxicol Sci; 2011 Nov; 124(1):215-24. PubMed ID: 21865289
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet adherence to mononuclear cells by alpha-tocopherol: role of P-selectin.
Murohara T; Ikeda H; Otsuka Y; Aoki M; Haramaki N; Katoh A; Takajo Y; Imaizumi T
Circulation; 2004 Jul; 110(2):141-8. PubMed ID: 15197142
[TBL] [Abstract][Full Text] [Related]
16. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib.
Connor DE; Exner T; Ma DD; Joseph JE
Thromb Haemost; 2010 May; 103(5):1044-52. PubMed ID: 20390225
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase C by phorbol ester increases red blood cell scramblase activity and external phosphatidylserine.
Barber LA; Palascak MB; Qi X; Joiner CH; Franco RS
Eur J Haematol; 2015 Nov; 95(5):405-10. PubMed ID: 25600460
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry.
Tomer A
J Biol Regul Homeost Agents; 2004; 18(2):172-7. PubMed ID: 15471223
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
[TBL] [Abstract][Full Text] [Related]
20. Caspase inhibition decreases both platelet phosphatidylserine exposure and aggregation: caspase inhibition of platelets.
Cohen Z; Wilson J; Ritter L; McDonagh P
Thromb Res; 2004; 113(6):387-93. PubMed ID: 15226093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]